S100A9 and MMP9 are associated with a poor prognosis of HCC and can promote the growth and metastasis of HCC cells by activating the MAPK signaling pathway and epithelial-mesenchymal transformation, respectively (77, 78, 79, 80). This evidence concerns the gene MMP9 and hepatocellular carcinoma.